We have commenced the post-listing review on shoulder humeral components listed on the Prescribed List (PL). The objective of this review is to review the current functionality and designs of humeral trays, metaphyseal components and humeral cups to determine the appropriate PL settings.
The review will explore the following questions:
- Are the current billing codes grouped according to similar device characteristics that reflect their use within implant constructs?
- Is there robust comparative clinical evidence that would justify appropriate PL benefits for components with specific device characteristics (e.g. inlay versus onlay conformation)?
- What PL groupings best reflect clinical and/or functional similarity?
- Using the proposed grouping structure, what are the appropriate PL benefits for the devices in scope?
The review will follow the process outlined in the post-listing review framework. The review will be an internal department review.
Sponsors and relevant stakeholders have been notified and invited to submit relevant information to inform the review.
Find out more on the progress of the review.